Similarly, Ptgs2 deletion in the YUMM3.3 RTT model resulted in tumour rejection in immunocompetent C57BL/6 mice in a T cell-dependent manner, even without ICB treatment (Fig. 3d and Extended Data Fig. 5f,g). The gene discussed is PTGS2; the disease is neoplasm.